Organs-On-Chips Market Size By End User, By Application, By Type (Liver, Heart), By Geographic Scope And Forecast
Organs-On-Chips Market Size By End User, By Application, By Type (Liver, Heart), By Geographic Scope And Forecast
Organs-On-Chips Market size was valued at USD 62.62 Million in 2021 and is projected to reach USD 386.29 Million by 2030, growing at a CAGR of 29.74% from 2022 to 2030.

Organs-On-Chips Market Size And Forecast

Organs-On-Chips Market size was valued at USD 62.62 Million in 2021 and is projected to reach USD 386.29 Million by 2030, growing at a CAGR of 29.74% from 2022 to 2030.

The important driver of the rise in Organs-On-Chips Market revenue is the increase in research funding and venture capital investments. This, together with an increasing emphasis on discovering alternatives to animal testing models, will promote market expansion. The Global Organs-On-Chips Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that play a substantial role in the market.

Global Organs-On-Chips Market Definition

Combining living cells on a scaffold made of organic or synthetic material is known as the technique of creating organs on chips. An organ-on-a-chip (OOC) is a microfluidic cell culture device made with continuously perfused containers populated by living cells designed to mimic tissue- and organ-level physiology. OOCs are made using microchip manufacturing processes. A new model of in vitro multicellular human creatures has been developed as a result of the ability of researchers to analyze human physiology in an organ-specific environment using labs-on-chips (LOCs) and cell biology.

For the blood and airflow in organs including the lung, gut, liver, heart, and others, this chip creates a small channel. Multiple degrees of tissue and organ functionality is produced by these devices, which are not possible utilizing traditional 2D and 3D culture systems. Applications for organ-on-chip include disease modeling, patient stratification, and phenotypic screening.

Get | Download Sample Report @

Global Organs-On-Chips Market Overview

The significant factors affecting the growth of the global organ-on-chip market are the surge in OOC device applications in the healthcare sector, the rise in demand for organ-on-chip in drug screening, the rise in demand for OOCs for lung- and kidney-based organ culture, the high cost of OOC devices, the early stages of OOC R&D, and the rise in research activities on OOC devices. These elements could help or hurt the market for organs on chips. The global market is anticipated to grow faster than average because of the spike in demand for organ-on-chip technologies in the healthcare sector. Real-time imaging, and in-vitro analysis of biochemical, genetic, and metabolic actions of existing cells in a functional tissue, which greatly drives their acceptance, are applications for organ-on-chip technologies.

Drug screening is a quick, affordable approach to examining samples. Researchers and scientists use organ-on-chip culture apparatuses to monitor the effects of medications on the body. This method also allows for the evaluation of drug toxicity or efficacy in other body organs, which promotes market expansion. Patient mortality as a result of the lack of donor’s lungs for transplantation has increased significantly. Therefore, it is projected that increased demand for creating functioning, laboratory-engineered organs will support market expansion. Recellularized solid organs can temporarily serve organ-specific functions, which represents the future therapeutic application of engineered solid organs.

Global Organs-On-Chips Market: Segmentation Analysis

The Global Organs-On-Chips Market is segmented on the basis of End User, Application, Type, And Geography.

Organs-On-Chips Market, By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cosmetics Industry
  • Other

Based on End User, The market is divided into the Cosmetics Industry, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Other. Organs-on-chip technology was used more frequently for drug development and testing as a result of the COVID-19 pandemic. Various partnerships between research institutions and market participants have been seen in the industry. For instance, the US Food and Drug Administration and Emulate collaborated to employ lung chips in October 2020 to assess the safety of COVID-19 vaccinations and the development of SARS-CoV-2 protective immunity. As a result, the segment for Pharmaceutical & Biotechnology Companies is anticipated to have the highest CAGR.

Organs-On-Chips Market, By Application

  • Physiological Model Development
  • Drug Discovery
  • Toxicology Research

Ask For Report Details @

Based on Application, The market is divided into Physiological Model Development, Drug Discovery, and Toxicology Research. Numerous prospects for expansion will arise from the rising incidence of chronic diseases, the lack of organ donors, the demand for early drug toxicity testing, and the introduction of new products. To acquire a competitive advantage, end goals can be determined and marketing strategies can be improved with the aid of a comprehensive analysis of the drivers and challenges. Hence During the forecast period, the drug discovery segment is anticipated to have the greatest CAGR.

Organs-On-Chips Market, By Type

  • Liver
  • Heart
  • Lung
  • Kidney
  • Others

Based on Type, the market is bifurcated into Liver, Heart, Lung, Kidney, and Others. Depending on the product, the lung-on-chip segment of the organ-on-chip industry dominates the market and is expected to remain dominant during the forecast period, owing to lower lung transplantations, which has led to the development of laboratory-engineered chips to mimic their functions and for drug screening for respiratory disorders.

Organs-On-Chips Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

On the basis of Regional Analysis, The Global Organs-On-Chips Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to account for the largest share and is also expected to grow at the highest CAGR of the market followed by Europe. The significant growth of the North American Organs-On-Chips Market is mostly due to the region’s expanding healthcare applications and cutting-edge technological advancements. The presence of top-tier researchers and scientists also contributes to the region’s industrial growth.

Moreover, the market growth is being fueled globally by the significant presence of top organ-on-chip suppliers and producers. These elements will ultimately fuel the need in the regional market for organ-on-chip products. It is projected that Asia-Pacific would increase its market share. The market in the region will increase as a result of rising disposable income among the populace and supportive government financing for regenerative medicine research institutes. The scale of the Organs-On-Chips Market will be boosted in the near future by product innovation, collaborative partnerships, and private-public strategic alliances.

Key Players

The “Global Organs-On-Chips Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as CN Bio Innovations, InSphero, BioIVT, Kirkstall, Visikol, SynVivo, AxoSim, Nortis, etc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. Along with it, the section also covers the development strategies, market share, and ranking analysis of leading market players.

For More Information @


About us –

Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. VMR offers insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.

We, at Verified Market Research assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.

Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research

US: +1 (650)-781-4080

UK: +44 (753)-715-0008

APAC: +61 (488)-85-9400

US Toll-Free: +1 (800)-782-1768



Try Our New Dashboard :-